Literature DB >> 35486078

Peripheral Blood Inflammation Profile of Patients with Pulmonary Arterial Hypertension Using the High-Throughput Olink Proteomics Platform.

Claudia Mickael1, Vitaly O Kheyfets1, Christophe Langouët-Astrié1, Michael H Lee2, Linda A Sanders1, Caio O Trentin1, Andrew J Sweatt3, Roham T Zamanian3, Todd M Bull1, Kurt Stenmark1, Brian B Graham2, Rubin M Tuder1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35486078      PMCID： PMC9116364          DOI： 10.1165/rcmb.2021-0369LE

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN： 1044-1549            Impact factor:   7.748


× No keyword cloud information.
  13 in total

1.  Modern age pathology of pulmonary arterial hypertension.

Authors:  Elvira Stacher; Brian B Graham; James M Hunt; Aneta Gandjeva; Steve D Groshong; Vallerie V McLaughlin; Marsha Jessup; William E Grizzle; Michaela A Aldred; Carlyne D Cool; Rubin M Tuder
Journal:  Am J Respir Crit Care Med       Date:  2012-06-07       Impact factor: 21.405

2.  Adjusting batch effects in microarray expression data using empirical Bayes methods.

Authors:  W Evan Johnson; Cheng Li; Ariel Rabinovic
Journal:  Biostatistics       Date:  2006-04-21       Impact factor: 5.899

Review 3.  Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch; Christophe Guignabert; Marc Humbert; Mark R Nicolls
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

Review 4.  Pulmonary vascular remodeling in pulmonary hypertension.

Authors:  Rubin M Tuder
Journal:  Cell Tissue Res       Date:  2016-12-26       Impact factor: 5.249

Review 5.  Novel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference Series).

Authors:  Keytam S Awad; James D West; Vinicio de Jesus Perez; Margaret MacLean
Journal:  Pulm Circ       Date:  2016-09       Impact factor: 3.017

6.  Interleukin-15 stimulates macrophages to activate CD4+ T cells: a role in the pathogenesis of rheumatoid arthritis?

Authors:  René Rückert; Katja Brandt; Martin Ernst; Kathleen Marienfeld; Elena Csernok; Claudia Metzler; Vadim Budagian; Elena Bulanova; Ralf Paus; Silvia Bulfone-Paus
Journal:  Immunology       Date:  2008-06-13       Impact factor: 7.397

7.  Discovery of Distinct Immune Phenotypes Using Machine Learning in Pulmonary Arterial Hypertension.

Authors:  Andrew J Sweatt; Haley K Hedlin; Vidhya Balasubramanian; Andrew Hsi; Lisa K Blum; William H Robinson; Francois Haddad; Peter M Hickey; Robin Condliffe; Allan Lawrie; Mark R Nicolls; Marlene Rabinovitch; Purvesh Khatri; Roham T Zamanian
Journal:  Circ Res       Date:  2019-03-15       Impact factor: 17.367

Review 8.  Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis.

Authors:  J Musa; M F Orth; M Dallmayer; M Baldauf; C Pardo; B Rotblat; T Kirchner; G Leprivier; T G P Grünewald
Journal:  Oncogene       Date:  2016-02-01       Impact factor: 9.867

Review 9.  The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.

Authors:  Steven C Pugliese; Jens M Poth; Mehdi A Fini; Andrea Olschewski; Karim C El Kasmi; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-21       Impact factor: 5.464

10.  TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension.

Authors:  Rahul Kumar; Claudia Mickael; Biruk Kassa; Liya Gebreab; Jeffrey C Robinson; Daniel E Koyanagi; Linda Sanders; Lea Barthel; Christina Meadows; Daniel Fox; David Irwin; Min Li; B Alexandre McKeon; Suzette Riddle; R Dale Brown; Leslie E Morgan; Christopher M Evans; Daniel Hernandez-Saavedra; Angela Bandeira; James P Maloney; Todd M Bull; William J Janssen; Kurt R Stenmark; Rubin M Tuder; Brian B Graham
Journal:  Nat Commun       Date:  2017-05-30       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.